Kinetic Study of In Vitro Release of Neem from Chitosan Biopolymer and Assessment of Its Biological Effectiveness

The study examined the sustained release of neem from the polymeric carrier system chitosan by varying the drug content, ionic strength of the release medium, and pH. Six different kinetic models, i.e., Korsmeyer-Peppas (KP), Peppas-Sahlin (PS), Higuchi, Hixson-Crowell, Zero order, and First order were used to investigate the drug release kinetics. Based on the R<sup>2</sup> values, the KP and PS models were chosen from the examined models to study the drug release mechanism from the chitosan biopolymer. The values found for model parameters <i>n</i> and <i>m</i> in the KP and PS models differ noticeably, suggesting that Fickian diffusion and Case II relaxation are important components of the neem release mechanism from chitosan. At lower ionic strengths and lower pH values, neem is released from the composite mostly by Fickian diffusion. The diphenyl-2-picrylhydrazyl assay served to assess the composite's antioxidant properties. The composite's antioxidant properties ranged from 3.56 ± 1.89% at 10 μg/mL to 51.28 ± 1.14% at 70 μg/mL. The ability of the composite to inhibit the denaturation of egg albumin was also tested and it ranged from 59.68 ± 0.93% at 25 μg/mL to 187.63 ± 3.53% at 1600 μg/mL. The drug composite has exhibited antibacterial activity against <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Escherichia coli</i>, and <i>Staphylococcus aureus</i>, and proved to be highly effective against <i>P. aeruginosa</i> at lower concentrations and against <i>S. aureus</i> at higher concentrations. The resulting inhibition zones for <i>P. aeruginosa</i> at 5 and 10 mg/mL concentrations were 16.5 ± 2.25 mm, and 14.83 ± 0.6 mm, respectively, whereas for <i>S. aureus,</i> it was 16.67 ± 0.33 mm at 20 mg/mL. The neem-chitosan composite's minimum inhibitory concentration/minimum bactericidal concentration ratio for <i>K. pneumoniae</i>, <i>P. aeruginosa</i>, and <i>S. aureus</i> was greater than 4, suggesting that they trigger bacteriostatic outcomes, whereas for <i>E. coli,</i> it was 4, which means that bactericidal effects were evident.

Authors

Institutions

Publication Details

Journal
Polymers
Published
2025-03-06
DOI
https://doi.org/10.3390/polym17050702
Citations
5
Primary Topic
Nanocomposite Films for Food Packaging
Type
article
Field-Weighted Citation Impact
2.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Kinetic Study of In Vitro Release of Neem from Chitosan Biopolymer and Assessment of Its Biological Effectiveness

Madara Jayanetti, Charitha Thambiliyagodage, Yasodani Nishshanka
5 citations
Polymers
Nanocomposite Films for Food Packaging
2.99
article

Kinetic Study of In Vitro Release of Neem from Chitosan Biopolymer and Assessment of Its Biological Effectiveness

Madara Jayanetti, Charitha Thambiliyagodage, Yasodani Nishshanka
article en
5 citations

Abstract

The study examined the sustained release of neem from the polymeric carrier system chitosan by varying the drug content, ionic strength of the release medium, and pH. Six different kinetic models, i.e., Korsmeyer-Peppas (KP), Peppas-Sahlin (PS), Higuchi, Hixson-Crowell, Zero order, and First order were used to investigate the drug release kinetics. Based on the R<sup>2</sup> values, the KP and PS models were chosen from the examined models to study the drug release mechanism from the chitosan biopolymer. The values found for model parameters <i>n</i> and <i>m</i> in the KP and PS models differ noticeably, suggesting that Fickian diffusion and Case II relaxation are important components of the neem release mechanism from chitosan. At lower ionic strengths and lower pH values, neem is released from the composite mostly by Fickian diffusion. The diphenyl-2-picrylhydrazyl assay served to assess the composite's antioxidant properties. The composite's antioxidant properties ranged from 3.56 ± 1.89% at 10 μg/mL to 51.28 ± 1.14% at 70 μg/mL. The ability of the composite to inhibit the denaturation of egg albumin was also tested and it ranged from 59.68 ± 0.93% at 25 μg/mL to 187.63 ± 3.53% at 1600 μg/mL. The drug composite has exhibited antibacterial activity against <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Escherichia coli</i>, and <i>Staphylococcus aureus</i>, and proved to be highly effective against <i>P. aeruginosa</i> at lower concentrations and against <i>S. aureus</i> at higher concentrations. The resulting inhibition zones for <i>P. aeruginosa</i> at 5 and 10 mg/mL concentrations were 16.5 ± 2.25 mm, and 14.83 ± 0.6 mm, respectively, whereas for <i>S. aureus,</i> it was 16.67 ± 0.33 mm at 20 mg/mL. The neem-chitosan composite's minimum inhibitory concentration/minimum bactericidal concentration ratio for <i>K. pneumoniae</i>, <i>P. aeruginosa</i>, and <i>S. aureus</i> was greater than 4, suggesting that they trigger bacteriostatic outcomes, whereas for <i>E. coli,</i> it was 4, which means that bactericidal effects were evident.

PolymersVol. 17(5)
Sri Lanka Institute of Information Technology (LK)
Openalex Percentile: Top 10%
Nanocomposite Films for Food Packaging
2.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.